Table:
begin	end	state
1	19	non-cytoplasmic
20	37	transmembrane
38	46	cytoplasmic
47	78	transmembrane
79	94	non-cytoplasmic
95	114	transmembrane
115	125	cytoplasmic
126	153	transmembrane
154	234	non-cytoplasmic
235	260	transmembrane
261	290	cytoplasmic
291	315	transmembrane
316	320	non-cytoplasmic
321	338	transmembrane
339	349	cytoplasmic
350	373	transmembrane
374	378	non-cytoplasmic
379	401	transmembrane
402	403	cytoplasmic
404	428	transmembrane
429	432	non-cytoplasmic
433	454	transmembrane
455	472	cytoplasmic
473	495	transmembrane
496	501	non-cytoplasmic

Input:
>HSERO_RS04820 FitnessBrowser__HerbieS:HSERO_RS04820
MLAQLKAAFKYFNDAVPFKLVPALIATAVLIALLLTPCPTGLEPKAWALVAIFLTTIVAI
ILKVMPIGVMAMMAIVIVSLSQVTSTSSKGAITDALASFSNPLIWLIVVAILISRGLKKT
GLGRRVGLMFIALLGKRTIGIGYGLAICELVLAPFTPSNTARGGGIVHPIMKSIANAFDS
DPAKGTQNKVGSYLALVNYHANPITSAMFLTATAPNPLVVNYVAKATGHALQLTWTTWAL
CMLLPGLVCLLIMPMVIYLLSPPELKSTPNAVDYARSELDKMGKLGASEKVMLGTFALLL
LLWANVPAMLLGAAFTLDPTVVAFVGLFVLIITGTIDWDDVLSEKSAWDTLVWFGALVML
AEQLNKTGVVAWFSEGMKAAIVASGMGWIAVAAVLLLVFVLSHYFFASTTAHISAMMLAF
LTVGAQLLPPQYVVPFMLMMTAGSGVMMTLTHYATGTSPIIFGSGYVSMGKWWGVGFVMA
VVELLVFATVGMVWWKGLGYW

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server